Acer Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

    NEXT STORY
    Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
    PREV STORY
    Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Five Prime Therapeutics to Present at the 25th Annual Credit Suisse Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

    author_avatar
    NASDAQ Market News

    Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval for Non-Opioid ZTlido™ (lidocaine topical system) 1.8% for PHN Pain

    SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) (“Sorrento”), and ...

    author_avatar
    NASDAQ Market News

    Cortice Biosciences Announces an Upcoming Presentation at the 2017 American Society of Clinical Oncology Annual Meeting

    NEW YORK, May 18, 2017 (GLOBE NEWSWIRE) -- Cortice Biosciences announced today that final ...

    author_avatar
    NASDAQ Market News